HORIBA Medical is informing all ABX PENTRA Urine Control L/H customers running the Creatinine assay
on ABX PENTRA Chemistry Analyzers that the Target Range for Creatinine has been updated. The ABX PENTRA Urine Control L/H lot specific annexes have been updated to
include revised acceptable Target Ranges for Creatinine.No other analyte values
are affected.
Source facts
Action
HORIBA Medical sent an Urgent Safety Notice dated December 18, 2013, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to update their Quality Control procedures to include the new Creatinine Target
Ranges for the ABX PENTRA Urine Control L/H Reference #: A11A01674 and Lot #s: 1207001, 1303601, and 1300701. Customers were instructed to complete and return the enclosed response form to verify their understanding of the Field Safety Notice. Customers with questions were instructed to contact their local HORIBA Medical representative.
For questions regarding this recall call 949-453-0500.
Initiated
2013-12-18
Root cause
Pending
Terminated
2014-10-09
Distribution
Worldwide Distribution - USA (nationwide) and Canada.
Recall number
Z-0924-2014
Recall status
Terminated
CDRH record ID
124753
FDA classified
2014-02-03
Recall event number
67133
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.